Skip to content

Clinical study to evaluate the efficacy and safety of improved Masquelet technique for Gustilo III type open fractures with bone defect.

Clinical study to evaluate the efficacy and safety of improved Masquelet technique for Gustilo III type open fractures with bone defect.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17011138
Enrollment
Unknown
Registered
2017-04-13
Start date
2017-05-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gustilo III type open fractures with bone defect

Interventions

Group A:improved Masquelet technique treatment

Sponsors

Daping Hospital, the Third Military Medical University, Chongqing, China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. In-patients aged from 18 to 65 years men and women; 2. Gustilo type III open fractures with bone defect at least 5cm; 3. subjects are Voluntary and sign the informed content, attending the research.

Exclusion criteria

Exclusion criteria: 1. in addition to the limbs open fracture merge in areas such as the head, chest, abdomen injury of multiple trauma; 2. pregnancy, or nursing mothers, or ready to pregnant women; 3. associated with other serious disease, including liver, kidney, cardiovascular disease; 4. NYHA class II ~ IV heart function failure or nearly 3 months of myocardial infarction, stroke and other cardiovascular events; 5. liver meritorious service is significantly abnormal, or any of the following history of liver disease: 2 times higher than normal amount of AST and ALT limit, liver cirrhosis, hepatic encephalopathy history, history of history of esophageal varices or portal vein shunt; 6. a history of renal damage evidence or the following kidney disease: serum creatinine 1.5 times higher than normal limit; The history of dialysis;History or nephrotic syndrome; 7. merge all sorts of acute infection, tumor and severe arrhythmia, mental system disorders, drug or alcohol addiction; 8. the bone cement, vancomycin allergies or have contraindications in past 3 months; 9. into the group or the group participated in other clinical trials; 10. you have any medical history, according to the researchers may interfere with the test result or increase the risk of patients; 11. difficult to complete the visitor, or the various factors influencing the compliance; 12. refused to sign the informed consent, do not agree to participate in the study.

Design outcomes

Primary

MeasureTime frame
erythrocyte sedimentation rate ;leukocyte;Neutrophils;C-reactive protein;

Countries

China

Contacts

Public ContactJun Fei

Daping Hospital, the Third Military Medical University, Chongqing, China

1163427207@qq.com+86 13883405501

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026